2 results

Helsinn is a privately owned pharmaceutical group with an extensive portfolio of cancer care products

Helsinn, a Swiss pharmaceutical group focused on building cancer care products, has announced a €6 million investment at its drug product supply centr(...)

Helsinn chief executive Ricardo Braglia: “I think 20 per cent could be a good rate, comparable to what we pay in Switzerland, which is 20 to 22 per cent. Probably there is a margin to move there from 12.5 to 15 per cent or maximum 20 per cent.” Photograph: Ken Lennox

Increasing Ireland’s corporate tax rate to about 20 per cent would probably not result in an exodus of overseas multinational investors, according to (...)